ClinConnect ClinConnect Logo
Search / Trial NCT06308328

A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Mar 12, 2024

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

Nasopharyngeal Carcinoma Radiotherapy Radiation Induced Oropharyngeal Mucositis Swallowing Induced Breakthrough Pain Delineation Method

ClinConnect Summary

This clinical trial is investigating a new method for predicting and understanding a painful condition called radiation-induced oropharyngeal mucositis, which can occur in patients with nasopharyngeal carcinoma (a type of throat cancer) undergoing radiation treatment. The researchers want to see if a special way of measuring the mucosa— the moist tissue in the throat—can help better predict how severe this condition might be and how it relates to pain when swallowing.

To participate in the study, you must be at least 18 years old, have a confirmed diagnosis of nasopharyngeal carcinoma, and be currently receiving radiation or chemoradiotherapy. You will need to be able to provide consent and have detailed records of your mucositis and any pain you experience while swallowing. Participants will be closely monitored throughout the study, and it aims to improve the understanding and management of this common side effect of cancer treatment. If you have any ongoing serious health conditions or certain dental issues, you may not be eligible.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Provide informed written consent.
  • 2. Age ≥ 18 years.
  • 3. Histologically confirmed as nasopharyngeal carcinoma, and currently undergoing radical radiotherapy or chemoradiotherapy.
  • 4. Complete and continuous records of oral / oropharyngeal mucositis grading, and self-reported swallowing-induced breakthrough pain.
  • Exclusion Criteria:
  • 1. Existence of poor oral hygiene, untreated dental or periodontal diseases, and metal dental restorations.
  • 2. Current untreated or unresolved conditions like unstable heart diseases requiring treatment, and poorly controlled diabetes mellitus.
  • 3. Body mass index (BMI) \<18.5.
  • 4. Unsuitable to participate in current study, according to researchers' assessment.

About Nanfang Hospital, Southern Medical University

Nanfang Hospital, affiliated with Southern Medical University, is a leading medical institution in China renowned for its comprehensive clinical services and commitment to advancing healthcare through research and education. As a clinical trial sponsor, Nanfang Hospital leverages its state-of-the-art facilities and a multidisciplinary team of expert researchers to conduct innovative studies aimed at improving patient outcomes and contributing to the global medical community. The hospital's focus on ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and scientific rigor.

Locations

Guangzhou, Guangdong, China

Guangzhou, Guangdong, China

Shanghai, Shanghai, China

Guangzhou, Guangdong, China

Guangzhou, Guangdong, China

Shenzhen, Guangdong, China

Guangzhou, Guangdong, China

Shaoguan, Guangdong, China

Zhuhai, Guangdong, China

Chendu, Sichuan, China

Patients applied

0 patients applied

Trial Officials

Jian Guan, Ph.D.

Principal Investigator

Nanfang Hospital, Southern Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported